Douglas A. Triplett

10.4k total citations · 3 hit papers
112 papers, 7.9k citations indexed

About

Douglas A. Triplett is a scholar working on Rheumatology, Hematology and Surgery. According to data from OpenAlex, Douglas A. Triplett has authored 112 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Rheumatology, 47 papers in Hematology and 19 papers in Surgery. Recurrent topics in Douglas A. Triplett's work include Systemic Lupus Erythematosus Research (51 papers), Blood Coagulation and Thrombosis Mechanisms (26 papers) and Platelet Disorders and Treatments (21 papers). Douglas A. Triplett is often cited by papers focused on Systemic Lupus Erythematosus Research (51 papers), Blood Coagulation and Thrombosis Mechanisms (26 papers) and Platelet Disorders and Treatments (21 papers). Douglas A. Triplett collaborates with scholars based in United States, Japan and United Kingdom. Douglas A. Triplett's co-authors include John T. Brandt, Barbara M. Alving, I. Scharrer, Takao Koike, Edward N. Harris, Robin L. Brey, Azzudin E. Gharavi, Ronald H. W. M. Derksen, Munther A. Khamashta and Jean‐Charles Piette and has published in prestigious journals such as JAMA, The Journal of Experimental Medicine and Journal of the American College of Cardiology.

In The Last Decade

Douglas A. Triplett

111 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop

1999 1.9k citations Wendell A. Wilson, Azzudin E. Gharavi et al. Arthritis & Rheumatism profile →
Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.

1995 965 citations Douglas A. Triplett et al. PubMed profile →
Criteria for the Diagnosis of Lupus Anticoagulants: An Update

1995 808 citations Douglas A. Triplett et al. profile →

Peers

Countries citing papers authored by Douglas A. Triplett

Since Specialization

Citations

This map shows the geographic impact of Douglas A. Triplett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas A. Triplett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas A. Triplett more than expected).

Fields of papers citing papers by Douglas A. Triplett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas A. Triplett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas A. Triplett. The network helps show where Douglas A. Triplett may publish in the future.

Co-authorship network of co-authors of Douglas A. Triplett

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas A. Triplett. A scholar is included among the top collaborators of Douglas A. Triplett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas A. Triplett. Douglas A. Triplett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	When to suspect hypercoagulability and how to investigate it 2001 ·Annals of Diagnostic Pathology ·Marisa B. Marques, Douglas A. Triplett	4
2	The Evaluation of Clotting Times in the Laboratory Detection of Lupus Anticoagulants 2001 ·Thrombosis Research ·E. Jacobsen, (unknown), Jeff Taylor, Douglas A. Triplett, Finn Wislöff	20
3	Oxidized Low-Density Lipoprotein and Autoimmune Antibodies in Patients With Antiphospholipid Syndrome With a History of Thrombosis 2001 ·American Journal of Clinical Pathology ·Dandan Zhao, (unknown), Xiang Wang, Gregory S. Cameron, (unknown), Jeffrey S. Dlott, Douglas A. Triplett	10
4	Use of the Dilute Russell Viper Venom Time (dRVVT): Its Importance and Pitfalls 2000 ·Journal of Autoimmunity ·Douglas A. Triplett	39
5	Proteolytic cleavage of β2-glycoprotein I: reduction of antigenicity and the structural relationship 2000 ·International Immunology ·Eiji Matsuura, Junko Inagaki, (unknown), Daisuke Yamamoto, Tatsuya Atsumi, Kazuko Kobayashi, Keiko Kaihara, Dandan Zhao, (unknown), Akito Tsutsumi, Tatsuji Yasuda, Douglas A. Triplett, (unknown)	25
6	Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats 1999 ·Blood Coagulation & Fibrinolysis ·(unknown), Keiji Aoshima, Tomoe Mizutani, Yasuo Ontachi, Mikako Saito, Eriko Morishita, Hidesaku Asakura, T Matsuda, Douglas A. Triplett	14
7	International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop breakdown → 1999 ·Arthritis & Rheumatism ·Wendell A. Wilson, Azzudin E. Gharavi, Takao Koike, Michael D. Lockshin, D. Ware Branch, Jean‐Charles Piette, Robin L. Brey, Ronald H. W. M. Derksen, Edward N. Harris, Graham R.V. Hughes, Douglas A. Triplett, Munther A. Khamashta	1917
8	Exogenous Estrogen May Exacerbate Thrombophilia, Impair Bone Healing and Contribute to Development of Chronic Facial Pain 1998 ·CRANIO® ·Charles J. Glueck, Robert E. McMahon, Jerry E. Bouquot, Douglas A. Triplett	16
9	Prothrombin Fragment 1+2 Measures Treatment Effect in Patients with Antiphospholipid Syndrome 1998 ·Thrombosis Research ·Masahide Yamazaki, Hidesaku Asakura, Masanori Saito, Hiroshi Jokaji, Chika Uotani, Ichiro Kumabashiri, Eriko Morishita, Keiji Aoshima, Tamotsu Matsuda, Douglas A. Triplett	4
10	PULMONARY EMBOLISM AND PREMATURE LABOR IN A PATIENT WITH BOTH FACTOR V LEIDEN MUTATION AND METHYLENETETRAHYDROFOLATE REDUCTASE GENE C677T MUTATION 1996 ·Thrombosis Research ·Fangyu Peng, Douglas A. Triplett, Linda K Barna, (unknown)	8
11	Anticoagulation monitoring: Accurate results with patient self-testing in a multicenter trial 1996 ·Journal of the American College of Cardiology ·Richard B. Becker, Daniel Becker, Maureen Andrew, Jack Ansell, Douglas A. Triplett, (unknown), (unknown), (unknown)	1
12	New Diagnostic Strategies for Lupus Anticoagulants and Antiphospholipid Antibodies 1994 ·Pathophysiology of Haemostasis and Thrombosis ·Douglas A. Triplett	15
13	Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. 1994 ·The Journal of Experimental Medicine ·Eiji Matsuura, Yoshiko Igarashi, Tatsuji Yasuda, Douglas A. Triplett, T. Koike	432
14	Isolation and characterization of TextarinR, a prothrombin activator from eastern brown snake (Pseudonaja textilis) venom 1994 ·Toxicon ·Kurt Stocker, (unknown), Christian Müller, Douglas A. Triplett	28
15	ARACHnase:An Evaluation of a Positive Control for Platelet Neutralization Procedure Testing With Seven Commercial Activated Partial Thromboplastin Time Reagents 1993 ·American Journal of Clinical Pathology ·David L. McGlasson, (unknown), (unknown), Douglas A. Triplett	8
16	Superwarfarin ingestion and detection 1991 ·American Journal of Hematology ·(unknown), Douglas A. Triplett, Michael J. Murphy, (unknown), James A. Sadowski, E G Bovill	34
17	Laboratory Diagnosis of Lupus Anticoagulants 1990 ·Seminars in Thrombosis and Hemostasis ·Douglas A. Triplett	33
18	Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: Problems and possible solutions 1989 ·La Ricerca in Clinica e in Laboratorio ·Linda K Barna, Douglas A. Triplett	9
19	Heparin: biochemistry, therapy, and laboratory monitoring. 1979 ·PubMed ·Douglas A. Triplett	9
20	Yersinia pseudotuberculosis mesenteric adenitis 1974 ·The Journal of Pediatrics ·(unknown), Douglas A. Triplett	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact